XLON:0J5Q

Hologic Stock Earnings Reports

etoro logo Buy 0J5Q
*Your capital is at risk
$74.22
+0.0027 (+0.0036%)
At Close: Nov 17, 2025

Hologic Earnings Calls

Sep 30, 2025
$1.13 (2.73%)
Release date Nov 03, 2025
EPS estimate $1.10
EPS actual $1.13
EPS Surprise 2.73%
Revenue estimate 1.081B
Revenue actual 1.05B
Revenue Surprise -2.92%
Jun 30, 2025
$0.86 (-18.49%)
Release date Jul 30, 2025
EPS estimate $1.06
EPS actual $0.86
EPS Surprise -18.49%
Revenue estimate 1.034B
Revenue actual 1.024B
Revenue Surprise -0.96%
Mar 30, 2025
$1.03 (0.98%)
Release date May 01, 2025
EPS estimate $1.02
EPS actual $1.03
EPS Surprise 0.98%
Revenue estimate 1.025B
Revenue actual 1.005B
Revenue Surprise -1.94%
Dec 31, 2024
$0.87 (-15.10%)
Release date Feb 05, 2025
EPS estimate $1.02
EPS actual $0.87
EPS Surprise -15.10%
Revenue estimate 1.022B
Revenue actual 1.022B
Revenue Surprise -0.0485%

Last 4 Quarters for Hologic

Below you can see how 0J5Q.L performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Dec 31, 2024 Missed
Release date Feb 05, 2025
Price on release $72.15
EPS estimate $1.02
EPS actual $0.87
EPS surprise -15.10%
Date Price
Jan 30, 2025 $71.88
Jan 31, 2025 $72.39
Feb 03, 2025 $71.39
Feb 04, 2025 $71.93
Feb 05, 2025 $72.15
Feb 06, 2025 $66.69
Feb 07, 2025 $65.50
Feb 10, 2025 $64.21
Feb 11, 2025 $65.25
4 days before 0.375%
4 days after -9.56%
On release day -7.57%
Change in period -9.22%
Mar 30, 2025 Beat
Release date May 01, 2025
Price on release $57.40
EPS estimate $1.02
EPS actual $1.03
EPS surprise 0.98%
Date Price
Apr 25, 2025 $57.69
Apr 28, 2025 $58.07
Apr 29, 2025 $58.08
Apr 30, 2025 $57.66
May 01, 2025 $57.40
May 02, 2025 $53.18
May 05, 2025 $52.88
May 06, 2025 $52.91
May 07, 2025 $55.90
4 days before -0.503%
4 days after -2.60%
On release day -7.36%
Change in period -3.09%
Jun 30, 2025 Missed
Release date Jul 30, 2025
Price on release $65.62
EPS estimate $1.06
EPS actual $0.86
EPS surprise -18.49%
Date Price
Jul 24, 2025 $66.16
Jul 25, 2025 $66.73
Jul 28, 2025 $66.73
Jul 29, 2025 $66.00
Jul 30, 2025 $65.62
Jul 31, 2025 $66.45
Aug 01, 2025 $66.27
Aug 04, 2025 $67.46
Aug 05, 2025 $67.64
4 days before -0.82%
4 days after 3.07%
On release day 1.26%
Change in period 2.23%
Sep 30, 2025 Beat
Release date Nov 03, 2025
Price on release $74.14
EPS estimate $1.10
EPS actual $1.13
EPS surprise 2.73%
Date Price
Oct 28, 2025 $73.99
Oct 29, 2025 $74.00
Oct 30, 2025 $74.04
Oct 31, 2025 $73.95
Nov 03, 2025 $74.14
Nov 04, 2025 $74.14
Nov 05, 2025 $74.20
Nov 06, 2025 $74.16
Nov 07, 2025 $74.18
4 days before 0.195%
4 days after 0.0594%
On release day 0.0054%
Change in period 0.255%

Hologic Earnings Call Transcript Summary of Q3 2025

Hologic reported Q3 fiscal 2025 revenue of $1.024 billion (up 0.4% YoY) and non-GAAP EPS of $1.08, both slightly above guidance. Diagnostics led performance while Breast Health showed sequential improvement driven by better commercial execution, interventional growth and the Endomag acquisition (contributed ~$20M in the quarter). Surgical grew (led by international expansion) and Skeletal rebounded as DEXA shipments resumed. The company maintained strong non-GAAP operating margin (~30%) and generated $343M operating cash flow, ending the quarter with $1.88B cash and a 0.6x net leverage ratio. Management completed strategic planning and expressed confidence in returning to mid-single-digit organic growth next year. Tariff headwinds were partially mitigated: the company now expects ~$10M–$12M per quarter of tariff expense going forward (roughly half the prior worst-case estimate). Q4 guidance: revenue $1.03B–$1.04B and non-GAAP EPS $1.09–$1.12; full-year guidance raised slightly to revenue $4.081B–$4.091B and EPS $4.23–$4.26. Key near-term drivers: continued recovery in Breast Health (gantry replacements, Envision launch timing), expansion of Panther/Fusion assay menu and Genius AI products, and integration/organic contribution from Endomag.

Hologic Earnings History

Earnings Calendar

FAQ

When is the earnings report for 0J5Q.L?
Hologic, Inc. (0J5Q.L) has scheduled its earnings report for Feb 03, 2026 before the markets open.

What is the 0J5Q.L price-to-earnings (P/E) ratio?
0J5Q.L P/E ratio as of Nov 17, 2025 (TTM) is 29.41.

What is the 0J5Q.L EPS forecast?
The forecasted EPS (Earnings Per Share) for Hologic, Inc. (0J5Q.L) for the first fiscal quarter 2025 is $.

What are Hologic, Inc.'s retained earnings?
On its balance sheet, Hologic, Inc. reported retained earnings of $1.05 billion for the latest quarter ending Sep 30, 2025.

What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.

Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.

What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE